ANNEX

Specific objective set out in point (a) of Article 3(2): participants number of legal entities involved (subdivided by size, type and country of establishment) collaborative research Measured by: number and value of funded projects cross-border collaboration: share of contracts awarded to SMEs and mid-caps, with value of contracts to cross-border collaboration share of recipients that did not carry out research activities with defence applications before 12 May 2021 innovation products Measured by: number of new patents deriving from projects supported by the Fund aggregated distribution of patents among SMEs, mid-caps and legal entities that are neither SMEs nor mid-caps aggregated distribution of patents per Member State Specific objective set out in point (b) of Article 3(2): collaborative capability development number and value of funded actions that address the capability shortfalls identified in the CDP continuous support throughout the full R & D cycle the presence in the background of IPRs or results generated in previously supported actions job creation/support number of supported defence R & D employees per Member State

← preamble_5 · All articles · anx_ANNEX__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-01 · Text as adopted (Official Journal); later amendments are not incorporated in this text.